These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21507137)

  • 1. Effectiveness of aripiprazole for medication overuse headache: a case report.
    Yamada K; Makihara Y; Imamura Y
    Psychiatry Clin Neurosci; 2011 Apr; 65(3):296-8. PubMed ID: 21507137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone.
    Martinotti G; Di Nicola M; Di Giannantonio M; Janiri L
    J Psychopharmacol; 2009 Mar; 23(2):123-9. PubMed ID: 18515460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of ECT with aripiprazole.
    Lopez-Garcia P; Chiclana C; Gonzalez R
    World J Biol Psychiatry; 2009; 10(4 Pt 3):942-3. PubMed ID: 17853257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia.
    Gründer G; Kungel M; Ebrecht M; Göröcs T; Modell S
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S21-5. PubMed ID: 16508892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination loxapine and aripiprazole for refractory hallucinations in schizophrenia.
    Sokolski KN
    Ann Pharmacother; 2011 Jul; 45(7-8):e36. PubMed ID: 21672885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole, alcohol and substance abuse: a review.
    Brunetti M; Di Tizio L; Dezi S; Pozzi G; Grandinetti P; Martinotti G
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16(10):1346-54. PubMed ID: 23104650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Aripiprazole in treatment resistant schizophrenia.
    Hughes D; Morcos M
    J Psychopharmacol; 2008 Nov; 22(8):927-8. PubMed ID: 18308805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aripiprazole induced Parkinsonism: A case report].
    Pasquier de Franclieu S; Germain C; Petitjean F
    Encephale; 2009 Oct; 35(5):496-8. PubMed ID: 19853725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
    Adan-Manes J; Garcia-Parajua P
    J Clin Pharm Ther; 2009 Apr; 34(2):245-6. PubMed ID: 19250146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA).
    Wolf J; Janssen F; Lublin H; Salokangas RK; Allain H; Smeraldi E; Bernardo M; Millar H; Pans M; Adelbrecht C; Laughton J; Werner C; Maier W
    Curr Med Res Opin; 2007 Oct; 23(10):2313-23. PubMed ID: 17706003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia.
    Sato G; Yoshimura S; Yamashita H; Okamoto Y; Yamawaki S
    Hiroshima J Med Sci; 2012 Dec; 61(4):75-83. PubMed ID: 23342824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole and haloperidol: beneficial combination antipsychotic therapy for a schizophrenic patient.
    Kuo J; Hwu HG
    Clin Neuropharmacol; 2008; 31(3):173-5. PubMed ID: 18520984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole in psychosis associated with Parkinson's disease.
    López-Meza E; Ruiz-Chow A; Ramirez-Bermudez J
    J Neuropsychiatry Clin Neurosci; 2005; 17(3):421-2. PubMed ID: 16179668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole: pharmacology, efficacy, safety and tolerability.
    Kinghorn WA; McEvoy JP
    Expert Rev Neurother; 2005 May; 5(3):297-307. PubMed ID: 15938662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of aripiprazole and quinagolide, a dopamine agonist, in a patient with symptomatic pituitary prolactinoma and chronic psychosis.
    Broekhof R; Gosselink MJ; Pijl H; Giltay EJ
    Gen Hosp Psychiatry; 2012; 34(2):209.e1-3. PubMed ID: 21872335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of restless legs syndrome and trichotillomania with aripiprazole.
    Virit O; Selek S; Savas HA; Kokaçya H
    J Clin Pharm Ther; 2009 Dec; 34(6):723-5. PubMed ID: 20175807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole: a new risk factor for pathological gambling? A report of 8 case reports.
    Gaboriau L; Victorri-Vigneau C; Gérardin M; Allain-Veyrac G; Jolliet-Evin P; Grall-Bronnec M
    Addict Behav; 2014 Mar; 39(3):562-5. PubMed ID: 24315783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective treatment of premenstrual violence in major depression: augmentation with aripiprazole.
    Yao YC; Chiang PH; Hsiao MC; Liu CY
    Chang Gung Med J; 2008; 31(4):402-6. PubMed ID: 18935799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.